Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01314326 · ClinicalTrials.gov registry record
Advanced Imaging for Glaucoma Study
A clinical trial, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 832
- Enrollment target
NCT01314326: Completed study, sponsored by Oregon Health and Science University.
NCT01314326 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 832 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01314326 has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 832 participants
- Enrollment target
Study Summary
The specific aims of the clinical studies are to: 1. Predict the development of glaucomatous visual field (VF) abnormality in glaucoma suspects and pre-perimetric glaucoma patients based on anatomic abnormalities detected by advanced imaging. 2. Predict the development of glaucomatous VF abnormality in glaucoma suspects and pre-perimetric glaucoma patients based on anatomic changes detected between successive advanced imaging tests. 3. Determine the sensitivity and specificity of glaucoma diagnosis based on advanced imaging tests.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 832 participants |
| Start Date | 2003-09 |
| Est. Completion | 2015-05-15 |
What the finished NCT01314326 record still lists
NCT01314326 is an observational study that tracks outcomes without assigning an intervention. The registered 832 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01314326 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01314326 about?
NCT01314326 is a clinical study titled "Advanced Imaging for Glaucoma Study". The specific aims of the clinical studies are to: 1. Predict the development of glaucomatous visual field (VF) abnormality in glaucoma suspects and pre-perimetric glaucoma patients based on anatomic abnormalities detected by advanced imaging. 2. Predict the development of glaucomatous VF abnormalit...
What is the current status of trial NCT01314326?
This trial is currently completed. The enrollment target is 832 participants. The study started on 2003-09. Estimated completion is 2015-05-15.
Who is sponsoring clinical trial NCT01314326?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06910553 · 832 participants
IBD Pregnancy Registry
- NCT07089706 · 832 participants · Phase 4
A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations
- NCT05067283 · 830 participants · Phase 1
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
- NCT06592924 · 830 participants · Phase 3
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia